| Type I interferon modulates monocyte recruitment and maturation in chronic inflammation PY Lee, YI Li, Y Kumagai, Y Xu, JS Weinstein, ES Kellner, DC Nacionales, ... The American journal of pathology 175 (5), 2023-2033, 2009 | 207 | 2009 |
| Association of time‐varying clearance of nivolumab with disease dynamics and its implications on exposure response analysis C Liu, J Yu, H Li, J Liu, Y Xu, P Song, Q Liu, H Zhao, J Xu, VE Maher, ... Clinical Pharmacology & Therapeutics 101 (5), 657-666, 2017 | 163 | 2017 |
| FDA approval summary: atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma SJ Casak, M Donoghue, L Fashoyin-Aje, X Jiang, L Rodriguez, YL Shen, ... Clinical Cancer Research 27 (7), 1836-1841, 2021 | 138 | 2021 |
| FDA approval summary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1 P Narayan, S Wahby, JJ Gao, L Amiri-Kordestani, A Ibrahim, E Bloomquist, ... Clinical cancer research 26 (10), 2284-2289, 2020 | 128 | 2020 |
| Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus Y Li, PY Lee, ES Kellner, M Paulus, J Switanek, Y Xu, H Zhuang, ... Arthritis research & therapy 12, 1-12, 2010 | 127 | 2010 |
| IL-1α modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil PY Lee, Y Kumagai, Y Xu, Y Li, T Barker, C Liu, ES Sobel, O Takeuchi, ... The journal of immunology 186 (3), 1747-1754, 2011 | 73 | 2011 |
| FDA approval summary: selumetinib for plexiform neurofibroma D Casey, S Demko, A Sinha, PS Mishra-Kalyani, Y Shen, S Khasar, ... Clinical Cancer Research 27 (15), 4142-4146, 2021 | 63 | 2021 |
| Pleiotropic IFN-dependent and-independent effects of IRF5 on the pathogenesis of experimental lupus Y Xu, PY Lee, Y Li, C Liu, H Zhuang, S Han, DC Nacionales, J Weinstein, ... The Journal of Immunology 188 (8), 4113-4121, 2012 | 63 | 2012 |
| FDA Approval summary: Pembrolizumab, atezolizumab, and cemiplimab-rwlc as single agents for first-line treatment of Advanced/Metastatic PD-L1–high NSCLC O Akinboro, E Larkins, LH Pai-Scherf, LN Mathieu, Y Ren, J Cheng, ... Clinical Cancer Research 28 (11), 2221-2228, 2022 | 61 | 2022 |
| Toll‐like receptor 7–stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus H Zhuang, S Han, Y Xu, Y Li, H Wang, LJ Yang, WH Reeves Arthritis & rheumatology 66 (1), 140-151, 2014 | 61 | 2014 |
| FDA approval summary: Nivolumab with ipilimumab and chemotherapy for metastatic non–small cell lung cancer, A collaborative project orbis review PJ Vellanki, F Mulkey, AA Jaigirdar, L Rodriguez, Y Wang, Y Xu, H Zhao, ... Clinical Cancer Research 27 (13), 3522-3527, 2021 | 49 | 2021 |
| Induced murine models of systemic lupus erythematosus Y Xu, L Zeumer, WH Reeves, L Morel Systemic lupus erythematosus: methods and protocols, 103-130, 2014 | 34 | 2014 |
| FDA approval summary: ivosidenib for the treatment of patients with advanced unresectable or metastatic, chemotherapy refractory cholangiocarcinoma with an IDH1 mutation SJ Casak, S Pradhan, LA Fashoyin-Aje, Y Ren, YL Shen, Y Xu, ... Clinical Cancer Research 28 (13), 2733-2737, 2022 | 33 | 2022 |
| Spatiotemporal distribution of landing tropical cyclones and disaster impact analysis in coastal China during 1990–2016 J Chou, W Dong, G Tu, Y Xu Physics and Chemistry of the Earth, Parts A/B/C 115, 102830, 2020 | 27 | 2020 |
| Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells JS Weinstein, MJ Delano, Y Xu, KM Kelly-Scumpia, DC Nacionales, Y Li, ... The Journal of Immunology 190 (8), 3916-3927, 2013 | 27 | 2013 |
| Functional diversity of benthic ciliate communities in response to environmental gradients in a wetland of Yangtze Estuary, China Y Xu, X Fan, A Warren, L Zhang, H Xu Marine pollution bulletin 127, 726-732, 2018 | 26 | 2018 |
| Template-dependent multiple displacement amplification for profiling human circulating RNA W Wang, Y Ren, Y Lu, Y Xu, SD Crosby, AM Di Bisceglie, X Fan Biotechniques 63 (1), 21-27, 2017 | 24 | 2017 |
| Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8+ T Cell Activation via Cross-Presentation in Type 1 Diabetes C Liu, RL Whitener, A Lin, Y Xu, J Chen, A Savinov, JW Leiding, ... Frontiers in immunology 10, 952, 2019 | 23 | 2019 |
| A novel mechanism for generating the interferon signature in lupus: opsonization of dead cells by complement and IgM H Zhuang, S Han, Y Li, D Kienhöfer, P Lee, S Shumyak, R Meyerholz, ... Arthritis & rheumatology 68 (12), 2917-2928, 2016 | 22 | 2016 |
| Maintenance of autoantibody production in pristane-induced murine lupus S Han, H Zhuang, Y Xu, P Lee, Y Li, JC Wilson, O Vidal, HS Choi, Y Sun, ... Arthritis research & therapy 17, 1-13, 2015 | 22 | 2015 |
Yiming YinBristol-Myers SquibbVerified email at pathology.ufl.edu
